Page last updated: 2024-08-24

tangeretin and silybin

tangeretin has been researched along with silybin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M1
Feng, SL; Li, YZ; Liu, CX; Liu, L; Liu, ZQ; Xie, Y; Yuan, ZW; Zhou, H1
Chen, SY; Pang, XC; Suguro, R; Xie, Y; Yuan, ZW; Zhu, YZ1

Other Studies

3 other study(ies) available for tangeretin and silybin

ArticleYear
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
    Journal of natural products, 1996, Volume: 59, Issue:3

    Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes

1996
Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies.
    Pharmacological research, 2018, Volume: 128

    Topics: Animals; ATP-Binding Cassette Transporters; Biological Availability; Caco-2 Cells; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dogs; Flavones; Humans; Madin Darby Canine Kidney Cells; Male; Mice, Inbred C57BL; Rats, Sprague-Dawley; Silybin

2018
Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism.
    Pharmacological research, 2020, Volume: 151

    Topics: Animals; Flavones; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protective Agents; Silybin

2020